Exparel 266 MG Per 20 ML Injection

DRUG5 trials

Sponsors

University of California, San Francisco, St. Luke's Hospital, Pennsylvania, University of Washington, McMaster University, Rothman Institute Orthopaedics

Conditions

AnesthesiaAnesthesia, LocalAnesthesia; FunctionalAnkle SurgeryBariatric Surgery CandidateFoot SurgeryOpioid UsePain, Postoperative

Phase 4

The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery

CompletedNCT03196505

University of California, San FranciscoBariatric Surgery Candidate, Pain, Postoperative

Start: 2017-12-04End: 2019-07-31Updated: 2020-11-25

Exparel Use in Bilateral TAP Blocks for Postoperative Pain Control

CompletedNCT03878888

St. Luke's Hospital, PennsylvaniaAnesthesia, Local, Postoperative Pain, Surgery

Start: 2019-01-15End: 2019-07-01Updated: 2020-12-17

Use of Exparel for Postoperative Analgesia Following Bariatric Surgery

McMaster UniversityPost Operative Pain

Start: 2019-08-31End: 2021-08-31Target: 80Updated: 2019-06-05

Liposomal Bupivacaine With Dexamethasone for Foot Surgery

Enrolling by invitationNCT06465992

Rothman Institute OrthopaedicsAnkle Surgery, Foot Surgery, Popliteal Nerve Block +1

Start: 2024-06-17End: 2025-06-30Target: 126Updated: 2024-06-20

Unknown Phase

Postoperative Analgesia in Laparoscopic Abdominal Surgery After Exparel Via TAP or Local Infiltration

University of WashingtonAnesthesia, Anesthesia; Functional, Anesthesia, Local +2

Start: 2019-08-31End: 2020-07-31Target: 150Updated: 2019-04-25